Abbreviations
- CMV:
-
Zytomegalievirus
- HSV:
-
Herpes-simplex-Virus
- PCR:
-
Polymerasekettenreaktion
Literatur
Grossi L, Ciccaglione AF, Marzio L (2017) Esophagitis and its causes: who is “guilty” when acid is found “not guilty”? World J Gastroenterol 23(17):3011–3016. https://doi.org/10.3748/wjg.v23.i17.3011
Scheppach W, Meesmann M (2015) Exfoliative esophagitis while taking dabigatran. Dtsch Med Wochenschr 140(7):515–518. https://doi.org/10.1055/s-0041-101313
Kim SH, Jeong JB, Kim JW, Koh SJ, Kim BG, Lee KL, Chang MS, Im JP, Kang HW, Shin CM (2014) Clinical and endoscopic characteristics of drug-induced esophagitis. World J Gastroenterol 20(31):10994–10999. https://doi.org/10.3748/wjg.v20.i31.10994
Davila M, Bresalier RS (2008) Gastrointestinal complications of oncologic therapy. Nat Clin Pract Gastroenterol Hepatol 5(12):682–696. https://doi.org/10.1038/ncpgasthep1277
Boyce HW Jr. (1998) Drug-induced esophageal damage: diseases of medical progress. Gastrointest Endosc 47(6):547–550. https://doi.org/10.1016/s0016-5107(98)70264-0
Jaspersen D (2000) Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf 22(3):237–249. https://doi.org/10.2165/00002018-200022030-00007
Becker B, Borovicka J, Zimmermann D (2014) Dabigatran-induzierte exfoliative Ösophagitis. Eine (noch?) seltene Manifestation von Thoraxschmerzen. Schweiz Med Forum 14(43):802–804
Frieling T (2018) Non-cardiac chest pain. Visc Med 34(2):92–96. https://doi.org/10.1159/000486440
Mueller S, Aigner T, Neureiter D, Stolte M (2006) Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. J Clin Pathol 59(11):1175–1180. https://doi.org/10.1136/jcp.2005.031922
Saleem F, Sharma A (2022) Drug induced esophagitis. In: StatPearls. StatPearls Publishing, Treasure Island
Bordea MA, Pirvan A, Sarban C, Margescu C, Leucuta D, Samasca G, Miu N (2014) Pill-induced erosive esophagitis in children. Clujul Med 87(1):15–18. https://doi.org/10.15386/cjm.2014.8872.871.mab1
Okada M, Okada K (2012) Exfoliative esophagitis and esophageal ulcer induced by dabigatran. Endoscopy 44(Suppl 2):E23–E24. https://doi.org/10.1055/s-0031-1291503
Toya Y, Nakamura S, Tomita K, Matsuda N, Abe K, Abiko Y, Orikasa S, Akasaka R, Chiba T, Uesugi N, Sugai T, Matsumoto T (2016) Dabigatran-induced esophagitis: the prevalence and endoscopic characteristics. J Gastroenterol Hepatol 31(3):610–614. https://doi.org/10.1111/jgh.13024
Zhang N, Liu XS, Li G, Liu T (2016) Dabigatran-induced esophagitis: a frequently overlooked adverse effect. Int J Cardiol 212:358–359. https://doi.org/10.1016/j.ijcard.2016.03.178
Zhou Y, Dai Y, Lu L, Fu Z (2020) Dabigatran-induced esophagitis: a case report. Medicine 99(17):e19890. https://doi.org/10.1097/MD.0000000000019890
Lin S, Wang Y, Zhang L, Guan W (2019) Dabigatran must be used carefully: literature review and recommendations for management of adverse events. Drug Des Devel Ther 13:1527–1533. https://doi.org/10.2147/dddt.S203112
Zografos GN, Georgiadou D, Thomas D, Kaltsas G, Digalakis M (2009) Drug-induced esophagitis. Dis Esophagus 22(8):633–637. https://doi.org/10.1111/j.1442-2050.2009.00972.x
Argueta EA, Pan J, Fine S (2020) An unusual case of esophagitis. Gastroenterology 158(1):e3–e4. https://doi.org/10.1053/j.gastro.2019.07.024
Shibagaki K, Taniguchi H, Goto D, Kobayashi K, Kinoshita Y (2016) Dabigatran-induced asymptomatic esophageal mucosal injury. Gastrointest Endosc 83(2):472–473. https://doi.org/10.1016/j.gie.2015.08.028 (discussion 474)
Ootani A, Hayashi Y, Miyagi Y (2014) Dabigatran-induced esophagitis. Clin Gastroenterol Hepatol 12(7):e55–e56. https://doi.org/10.1016/j.cgh.2013.09.010
Fujikawa K, Takasugi N, Goto T, Minatoguchi S (2017) Very late-onset dabigatran-induced esophageal injury. Can J Cardiol 33(4):554.e15–554.e16. https://doi.org/10.1016/j.cjca
Kajihara Y (2019) Dabigatran-induced esophagitis. Cleve Clin J Med 86(5):303–304. https://doi.org/10.3949/ccjm.86a.18117
Iwamuro M, Matsushita H, Tanaka T, Okada H (2021) Dabigatran-induced esophagitis masking esophageal cancer. Dig Liver Dis 53(2):251–252. https://doi.org/10.1016/j.dld.2020.05.019
Boehringer-Ingelheim Fachinformation Pradaxa Hartkapseln. Anhang I. Zusammenfassung der Merkmale des Arzneimittels. (Stand: 01/2023) 44.
Desai J, Granger CB, Weitz JI, Aisenberg J (2013) Novel oral anticoagulants in gastroenterology practice. Gastrointest Endosc 78(2):227–239. https://doi.org/10.1016/j.gie.2013.04.179
Cox R, Roche E, Fairley S (2016) Novel oral anticoagulant drugs and severe oesophagitis dissecans. Intern Med J 46(12):1456–1457. https://doi.org/10.1111/imj.13275
Kono Y, Miyahara K, Nakagawa M (2020) A case of esophagitis induced by apixaban. J Gastrointestin Liver Dis 29(3):471. https://doi.org/10.15403/jgld-2685
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A.-M. Tiefenthaller, D. Schiller und R. Schöfl geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patient/-innen zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern/Vertreterinnen eine schriftliche Einwilligung vor.
Additional information
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
Rights and permissions
About this article
Cite this article
Tiefenthaller, AM., Schiller, D. & Schöfl, R. Von Weinsäure zu Weinbeere – eine ungewöhnliche Form der Ösophagitis. J. Gastroenterol. Hepatol. Erkr. 21, 30–32 (2023). https://doi.org/10.1007/s41971-023-00144-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41971-023-00144-5